Acquired resistance to isoniazid during isoniazid monotherapy in a subject with latent infection following household rifampicin-resistant tuberculosis contact: A case report

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Appropriate treatment is the key element in eliminating tuberculosis (TB), and requires prompt diagnosis. We presented a case of a household contact of rifampicin-resistant TB revealing reactive IFN-gamma release assay with unsuspicious clinical and radiologic examinations. She was diagnosed with latent tuberculosis infection (LTBI) and treated with isoniazid monotherapy. On the ninth month, she developed a progressive cough and was found to harbor active TB disease with added resistance to isoniazid. An individualized anti-TB regimen consisting of moxifloxacin, kanamycin, prothionamide, ethambutol, and pyr-azinamide was prescribed for 20 months, leading to sputum culture conversion and improve-ment of the reported symptom. No recurrence was observed on one-year follow-up. Assuming high compliance to therapy, we propose that the patient may have been under-diagnosed and received sub-optimal treatment leading to acquired-drug resistance. Conventional diagnosis methods based on immunological assay and radiographical findings may be insufficient to distinguish the incipient and subclinical states of TB from LTBI.

References Powered by Scopus

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

1397Citations
N/AReaders
Get full text

Three months of rifapentine and isoniazid for latent tuberculosis infection

808Citations
N/AReaders
Get full text

Incipient and subclinical tuberculosis: A clinical review of early stages and progression of infection

385Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis

8Citations
N/AReaders
Get full text

Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, T. L., Chan, T. H., Wang, C. H., Jou, R., Yu, M. C., Putri, D. U., … Lin, Y. H. (2021). Acquired resistance to isoniazid during isoniazid monotherapy in a subject with latent infection following household rifampicin-resistant tuberculosis contact: A case report. Infection and Drug Resistance, 14, 1505–1509. https://doi.org/10.2147/IDR.S304799

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

56%

Researcher 2

22%

Professor / Associate Prof. 1

11%

Lecturer / Post doc 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

38%

Nursing and Health Professions 3

38%

Biochemistry, Genetics and Molecular Bi... 1

13%

Pharmacology, Toxicology and Pharmaceut... 1

13%

Save time finding and organizing research with Mendeley

Sign up for free